ACW 6.67% 3.2¢ actinogen medical limited

US Senate passes bill to spend $2.3 billion on Alzheimers

  1. 1,951 Posts.
    lightbulb Created with Sketch. 93
    the Senate spending plan also provides $2.3 billion for additional Alzheimer’s research. The Associated Press reported that the increase in spending is “essentially quadrupling spending levels” set four years ago “on a disease that requires hundreds of billions of dollars for dementia-related care.” Sen. Roy Blunt, a Missouri Republican and chair of the Appropriations subcommittee on labor and health, said if the United States does not find a solution to Alzheimer’s disease by 2050, “we will be spending about twice today’s defense budget on Alzheimer’s care,” the AP reported.
    Alzheimer’s disease, a form of dementia, is the sixth-leading cause of death in the United States, according to the Alzheimer’s Association. While it’s one of the leading causes of death, the drug companies developing treatments for this disease are running into a new problem (beyond not having been very successful in late-stage development). The problem is too few Alzheimer’s patients are participating in clinical trials

    1) what a triumph it would be if Xanamem worked
    2) shows what excellent management we have with trial on schedule.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $74.60M
Open High Low Value Volume
3.0¢ 3.2¢ 2.8¢ $52.54K 1.749M

Buyers (Bids)

No. Vol. Price($)
1 11059 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 154422 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
3.1¢
  Change
0.002 ( 6.90 %)
Open High Low Volume
2.9¢ 3.1¢ 2.9¢ 855992
Last updated 15.54pm 29/03/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.